Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...
Irish Examiner on MSN7h
Weight loss drug Wegovy set to be made available in Ireland
The European Medicines Agency (EMA) has advised that the drug can be used together with diet and physical activity to help ...
SAP Topples Novo to Become Europe’s Most-Valuable Listed Company
SAP SE claimed the title of Europe’s most valuable public company, replacing Danish weight-loss drug maker Novo Nordisk A/S.
Finbold11h
U.S. Senator makes super suspicious healthcare stock trade
A United States Senator has disclosed a series of stock trades, some raising questions about possible insider information use ...